Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.8669
-0.0057-0.65%
Post-market: 0.89420.0273+3.15%16:27 EDT
Volume:344.12K
Turnover:300.06K
Market Cap:40.52M
PE:-0.96
High:0.9170
Open:0.8818
Low:0.8511
Close:0.8726
Loading ...
Sep 20, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 25, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 19, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
May 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 07, 2021

Major Issues Report

8-K - Current report
May 07, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 19, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 15, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]